Legend Biotech (ADR)
Commercializes CARVYKTI while developing next-generation CAR-T therapies.
$20.20
After-hours close+0.32 (+1.64%)
At close$19.88(−3.05%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.02 | — | — |
| Aug 2026 | $0.12 | $0.09 | −25.0% |
| May 2026 | −$0.02 | −$0.15 | −650.0% |
| Mar 2026 | −$0.17 | −$0.08 | +52.9% |
| Nov 2025 | −$0.13 | −$0.11 | +15.4% |
The latest year is open to everyone — the 25 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Sep 2022 | |||
| Jun 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| Jun 2020 | |||
| Dec 2019 | |||
| Sep 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 11, 2026 | $0.02 | — | — | $361.4M | — | — |
| Aug 11, 2026 | $0.12 | $0.09 | −25.0% | $356.0M | $387.5M | +8.9% |
| May 12, 2026 | −$0.02 | −$0.15 | −650.0% | $306.5M | $305.1M | −0.5% |
| Mar 10, 2026 | −$0.17 | −$0.08 | +52.9% | $307.8M | $306.3M | −0.5% |
| Nov 12, 2025 | −$0.13 | −$0.11 | +15.4% | $309.5M | $272.3M | −12.0% |
The latest year is open to everyone — the 25 quarters behind it read with an account. Sign in | ||||||
| Aug 11, 2025 | ||||||
| May 13, 2025 | ||||||
| Mar 11, 2025 | ||||||
| Aug 9, 2024 | ||||||
| May 13, 2024 | ||||||
| Mar 11, 2024 | ||||||
| Nov 20, 2023 | ||||||
| Aug 15, 2023 | ||||||
| May 18, 2023 | ||||||
| Mar 30, 2023 | ||||||
| Sep 30, 2022 | ||||||
| Jun 1, 2022 | ||||||
| Mar 18, 2022 | ||||||
| Dec 31, 2021 | ||||||
| Nov 16, 2021 | ||||||
| Aug 23, 2021 | ||||||
| May 18, 2021 | ||||||
| Mar 18, 2021 | ||||||
| Nov 16, 2020 | ||||||
| Aug 28, 2020 | ||||||
| Jun 8, 2020 | ||||||
| Dec 31, 2019 | ||||||
| Sep 30, 2019 | ||||||
| Jun 30, 2019 | ||||||
| Mar 31, 2019 | ||||||